Capital Advisors, Ltd. LLC Bristol Myers Squibb CO Transaction History

Capital Advisors, Ltd. LLC

$759 Million
Q1 2025

A detailed history of Capital Advisors, Ltd. LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 3,165 shares of BMY stock, worth $148,280. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,165

Previous 2,659 19.03%

Holding current value

$148,280

Previous $150,000 28.67%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	BUY	$53.9 - $63.11 $27,273 - $31,933	506 Added 19.03%	3,165 $193,000
Q4 2024 Feb 04, 2025	BUY	$51.92 - $59.94 $10,799 - $12,467	208 Added 8.49%	2,659 $150,000
Q3 2024 Oct 24, 2024	SELL	$39.66 - $51.75 $119,614 - $156,078	-3,016 Reduced 55.17%	2,451 $127,000
Q2 2024 Jul 25, 2024	BUY	$40.25 - $52.99 $2,898 - $3,815	72 Added 1.33%	5,467 $227,000
Q1 2024 Apr 18, 2024	SELL	$47.98 - $54.4 $145,859 - $165,376	-3,040 Reduced 36.04%	5,395 $293,000
Q4 2023 Feb 02, 2024	BUY	$48.48 - $57.85 $25,161 - $30,024	519 Added 6.56%	8,435 $433,000
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $30,276 - $33,853	523 Added 7.07%	7,916 $459,000
Q2 2023 Jul 26, 2023	BUY	$63.71 - $70.74 $20,705 - $22,990	325 Added 4.6%	7,393 $473,000
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $26,283 - $29,812	-400 Reduced 5.36%	7,068 $490,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $28,830 - $34,138	421 Added 5.97%	7,468 $504,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $808 - $477,714	6,217 Added 749.04%	7,047 $501,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $1,815 - $1,999	25 Added 3.11%	830 $64,000
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $1,291 - $1,548	21 Added 2.68%	805 $59,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $3,485 - $4,063	65 Added 9.04%	784 $49,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $57 - $65	1 Added 0.14%	719 $45,000
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $57 - $63	1 Added 0.14%	718 $43,000
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $54 - $64	1 Added 0.14%	717 $42,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $9,891 - $12,902	201 Added 39.03%	716 $46,000
Q3 2019 Oct 23, 2019	SELL	$42.77 - $50.71 $53,890 - $63,894	-1,260 Reduced 70.99%	515 $26,000
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $214,577 - $237,276	-4,809 Reduced 73.04%	1,775 $80,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $541 - $645	12 Added 0.18%	6,584 $314,000
Q4 2018 Jan 29, 2019	BUY	$48.76 - $63.23 $487 - $632	10 Added 0.15%	6,572 $342,000
Q3 2018 Oct 24, 2018	BUY	$55.19 - $62.25 $551 - $622	10 Added 0.15%	6,562 $407,000
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $505 - $629	10 Added 0.15%	6,552 $363,000
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $479 - $551	8 Added 0.12%	6,542 $414,000
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $479 - $522	8 Added 0.12%	6,534 $400,000
Q3 2017 Oct 25, 2017	BUY	$55.23 - $63.74 $360,430 - $415,967	6,526	6,526 $416,000

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Bristol Myers Squibb CO Transaction History